Clinical Trials Browser

Phase 1/2 × Suspended × Plasma cell × Clear all

NCT06232044 2026-03-04

Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory Multiple Myeloma

Phase 1/2 Suspended

Multiple Myeloma

NCT04505813 2024-01-16

Antigen-specific T Cell Therapy for Patients With Relapsed Refractory Multiple Myeloma

Phase 1/2 Suspended

Multiple Myeloma